Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Neuropathol Commun ; 10(1): 37, 2022 03 19.
Article in English | MEDLINE | ID: mdl-35305685

ABSTRACT

Machado-Joseph disease (MJD) or Spinocerebellar ataxia type 3 (SCA3) is the most common form of dominant SCA worldwide. Magnetic Resonance Imaging (MRI) and Proton Magnetic Resonance Spectroscopy (1H-MRS) provide promising non-invasive diagnostic and follow-up tools, also serving to evaluate therapies efficacy. However, pre-clinical studies showing relationship between MRI-MRS based biomarkers and functional performance are missing, which hampers an efficient clinical translation of therapeutics. This study assessed motor behaviour, neurochemical profiles, and morphometry of the cerebellum of MJD transgenic mice and patients aiming at establishing magnetic-resonance-based biomarkers. 1H-MRS and structural MRI measurements of MJD transgenic mice were performed with a 9.4 Tesla scanner, correlated with motor performance on rotarod and compared with data collected from human patients. We found decreased cerebellar white and grey matter and enlargement of the fourth ventricle in both MJD mice and human patients as compared to controls. N-acetylaspartate (NAA), NAA + N-acetylaspartylglutamate (NAA + NAAG), Glutamate, and Taurine, were significantly decreased in MJD mouse cerebellum regardless of age, whereas myo-Inositol (Ins) was increased at early time-points. Lower neurochemical ratios levels (NAA/Ins and NAA/total Choline), previously correlated with worse clinical status in SCAs, were also observed in MJD mice cerebella. NAA, NAA + NAAG, Glutamate, and Taurine were also positively correlated with MJD mice motor performance. Importantly, these 1H-MRS results were largely analogous to those found for MJD in human studies and in our pilot data in human patients. We have established a magnetic resonance-based biomarker approach to monitor novel therapies in preclinical studies and human clinical trials.


Subject(s)
Machado-Joseph Disease , Animals , Biomarkers , Cerebellum/diagnostic imaging , Cerebellum/pathology , Glutamic Acid , Humans , Machado-Joseph Disease/pathology , Mice , Mice, Transgenic , Taurine
2.
Mol Ther ; 26(9): 2131-2151, 2018 09 05.
Article in English | MEDLINE | ID: mdl-30087083

ABSTRACT

Machado-Joseph disease (MJD) or spinocerebellar ataxia type 3, the most common dominant spinocerebellar ataxia (SCA) worldwide, is caused by over-repetition of a CAG repeat in the ATXN3/MJD1 gene, which translates into a polyglutamine tract within the ataxin-3 protein. There is no treatment for this fatal disorder. Despite evidence of the safety and efficacy of mesenchymal stromal cells (MSCs) in delaying SCA disease progression in exploratory clinical trials, unanticipated regression of patients to the status prior to treatment makes the investigation of causes and solutions urgent and imperative. In the present study, we compared the efficacy of a single intracranial injection with repeated systemic MSC administration in alleviating the MJD phenotype of two strongly severe genetic rodent models. We found that a single MSC transplantation only produces transient effects, whereas periodic administration promotes sustained motor behavior and neuropathology alleviation, suggesting that MSC therapies should be re-designed to get sustained beneficial results in clinical practice. Furthermore, MSC promoted neuroprotection, increased the levels of GABA and glutamate, and decreased the levels of Myo-inositol, which correlated with motor improvements, indicating that these metabolites may serve as valid neurospectroscopic biomarkers of disease and treatment. This study makes important contributions to the design of new clinical approaches for MJD and other SCAs/polyglutamine disorders.


Subject(s)
Ataxin-3/metabolism , Machado-Joseph Disease/metabolism , Machado-Joseph Disease/therapy , Animals , Ataxin-3/genetics , Glutamic Acid/metabolism , Male , Mesenchymal Stem Cell Transplantation/methods , Mesenchymal Stem Cells/physiology , Mice , Mice, Inbred C57BL , Mice, Transgenic , gamma-Aminobutyric Acid/metabolism
3.
Ultrasound Med Biol ; 38(10): 1811-9, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22920547

ABSTRACT

A statistical approach was implemented in the study of histologic characteristics from ex vivo basal cell carcinomas, based on the properties of backscattered acoustic waves, for the purpose of evaluating the method as a diagnostic tool. The study was developed using an ultrasound biomicroscope working at a frequency of 45 MHz. The parameters examined were signal-to-noise ratio (SNR), and shape parameters from the Weibull (b(W)) and generalized gamma (c(GG) and υ(GG)) probability density functions. Twenty-seven carcinomatous skin samples were obtained from volunteer patients and classified into two groups (BCC1 and BCC2) based on the distribution patterns of their tumor nests; also, seven non-tumoral samples were used for comparative purposes. Significant differences between groups were obtained for all studied parameters. The successful differentiation between some tissue groups suggests its potential use for carcinoma characterization.


Subject(s)
Carcinoma, Basal Cell/diagnostic imaging , Carcinoma, Basal Cell/pathology , Image Interpretation, Computer-Assisted/methods , Microscopy, Acoustic/methods , Skin Neoplasms/diagnostic imaging , Skin Neoplasms/pathology , Data Interpretation, Statistical , Humans , Radiation Dosage , Reproducibility of Results , Scattering, Radiation , Sensitivity and Specificity , Sound
SELECTION OF CITATIONS
SEARCH DETAIL